- Home
- CIGL vs VYGR Comparison
CIGL vs VYGR Comparison
Compare CIGL & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGL
- VYGR
- Stock Information
- Founded
- CIGL 1997
- VYGR 2013
- Country
- CIGL Singapore
- VYGR United States
- Employees
- CIGL N/A
- VYGR N/A
- Industry
- CIGL Diversified Commercial Services
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- CIGL Consumer Discretionary
- VYGR Health Care
- Exchange
- CIGL Nasdaq
- VYGR Nasdaq
- Market Cap
- CIGL 145.9M
- VYGR 156.0M
- IPO Year
- CIGL 2025
- VYGR 2015
- Fundamental
- Price
- CIGL $6.59
- VYGR $2.97
- Analyst Decision
- CIGL
- VYGR Strong Buy
- Analyst Count
- CIGL 0
- VYGR 8
- Target Price
- CIGL N/A
- VYGR $14.33
- AVG Volume (30 Days)
- CIGL 16.5K
- VYGR 841.7K
- Earning Date
- CIGL 01-01-0001
- VYGR 08-05-2025
- Dividend Yield
- CIGL N/A
- VYGR N/A
- EPS Growth
- CIGL N/A
- VYGR N/A
- EPS
- CIGL N/A
- VYGR N/A
- Revenue
- CIGL $10,490,668.00
- VYGR $66,958,000.00
- Revenue This Year
- CIGL N/A
- VYGR N/A
- Revenue Next Year
- CIGL N/A
- VYGR $78.88
- P/E Ratio
- CIGL N/A
- VYGR N/A
- Revenue Growth
- CIGL N/A
- VYGR N/A
- 52 Week Low
- CIGL $3.63
- VYGR $2.65
- 52 Week High
- CIGL $7.80
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- CIGL N/A
- VYGR 41.86
- Support Level
- CIGL N/A
- VYGR $3.24
- Resistance Level
- CIGL N/A
- VYGR $3.64
- Average True Range (ATR)
- CIGL 0.00
- VYGR 0.27
- MACD
- CIGL 0.00
- VYGR -0.02
- Stochastic Oscillator
- CIGL 0.00
- VYGR 6.17
About CIGL Concorde International Group Ltd Class A Ordinary Shares
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.